# O que a ciência nos ensina sobre o Câncer de Mama | Felipe Zerwes | TEDxUnisinos

Source: https://www.youtube.com/watch?v=CXdR_KoexjQ
Recap page: https://rapidrecap.app/video/CXdR_KoexjQ
Generated: 2026-03-03T21:02:01.462+00:00

---
## Quick Overview

The presentation by Felipe Zerwes at TEDxUnisinos emphasizes the critical importance of early diagnosis and advanced personalized medicine in combating breast cancer, contrasting poor survival rates in low HDI countries with better outcomes elsewhere, and advocating for public engagement and lifestyle changes to mitigate risk.

**Key Points:**
- Breast cancer incidence is projected to increase by 38% and mortality by 68% globally by 2050, with the highest mortality rates (55%) occurring in low Human Development Index (HDI) countries.
- Being female and aging are non-modifiable risk factors, while lifestyle factors like obesity and alcohol consumption can be modified to prevent 25% of new cases.
- Early diagnosis significantly improves survival rates; patients diagnosed early have better survival probability compared to those diagnosed with advanced stages, especially in public health systems (P < 0.001 for all patients).
- Advanced treatments, like the antibody-drug conjugate described (Ado-trastuzumab emtansine), function as targeted 'Trojan horses' to deliver potent chemotherapy directly to tumor cells, minimizing systemic side effects.
- The speaker calls for greater public participation in health policy decisions, such as public consultations, to ensure equitable access to advanced treatments and technologies within the public health system.
- The speaker contrasts the high cost of treating advanced-stage cancer versus earlier stages, suggesting that early detection saves both lives and financial resources for the public health system.

![Screenshot at 2:18: A slide displaying graphical projections showing that breast cancer cases are expected to increase by 38% and mortality by 68% by 2050 across different HDI levels, highlighting the urgency of the issue.](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-02-18.jpg)

**Context:** Felipe Zerwes, a speaker at TEDxUnisinos, delivers a presentation focused on breast cancer, contrasting global epidemiological trends with the potential of personalized medicine and early detection. He uses striking statistics comparing survival rates between high and low HDI countries and discusses the mechanism of advanced targeted therapies, ultimately calling for greater public awareness and involvement in health policy decisions to improve equitable care access.

## Detailed Analysis

Felipe Zerwes begins by setting the stage with the grim projection that breast cancer incidence will rise by 38% and mortality by 68% by 2050, noting that countries with low HDI face a disproportionately high mortality rate of 55% compared to 17% in very high HDI countries. He points out that while factors like gender and age are non-modifiable risks, lifestyle choices (obesity, alcohol) could prevent 25% of new cases. Zerwes then transitions to personalized medicine, illustrating a targeted therapy (Ado-trastuzumab emtansine) as a 'Trojan Horse' that delivers potent chemotherapy directly to HER2-positive tumor cells, offering effective treatment with fewer side effects than traditional methods. He presents data showing a significant survival difference between private and public health system patients, particularly for advanced cases. The speaker urges the audience to promote early diagnosis, which he claims saves lives and reduces the financial burden on the public health system. He concludes by advocating for public participation in policy decisions, such as public consultations on incorporating new technologies, ensuring that personalized medicine benefits everyone, not just those in privileged socioeconomic strata.

### Breast Cancer Projections

- Incidence up 38% and mortality up 68% by 2050
- Highest mortality (55%) in low HDI countries
- Early diagnosis significantly improves survival.

### Risk Factors & Prevention

- Non-modifiable risks include being female and aging
- Modifiable lifestyle factors (obesity, alcohol) could prevent 25% of new cases.

### Advanced Therapy

- Targeted drugs act like the Trojan Horse, delivering chemotherapy directly to tumor cells (Anti-HER2 mAb mechanism shown)
- This allows for more effective and less toxic treatment.

### Health System Disparity

- Survival probability for breast cancer is significantly better for patients in private health systems compared to public systems (P < 0.001 for all patients).

### Call to Action

- Urges the audience to actively participate in public consultations regarding the inclusion of new medicines and technologies in the public health system to reduce inequality.

![Screenshot at 0:02: Title slide displaying the presentation theme: "VERDADE ou CONSEQUÊNCIA?"](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-00-02.jpg)
![Screenshot at 2:18: Slide showing future burden projections for female breast cancer incidence \(38% increase\) and mortality \(68% increase\) by 2050, categorized by HDI level.](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-02-18.jpg)
![Screenshot at 2:52: Slide illustrating non-modifiable risk factors for breast cancer: being female, aging, and genetic predisposition \(pedigree chart\).](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-02-52.jpg)
![Screenshot at 4:08: A composite slide showing two women who bravely shared their stories publicly, alongside an image illustrating the concept of a multi-disciplinary team meeting.](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-04-08.jpg)
![Screenshot at 6:02: Graph showing breast cancer mortality difference according to the health system \(Private vs. Public\), indicating lower survival probability for public system patients, especially in advanced cases.](https://ss.rapidrecap.app/screens/CXdR_KoexjQ/00-06-02.jpg)